Azithromycin has a tissue half-life of approximately 68 hours, allowing 3–5 day courses for infections. This is explained by:

• A High plasma protein binding maintaining a large plasma reservoir
• B Hepatic metabolism to an active metabolite with longer half-life
• C Renal tubular reabsorption creating an enterohepatic cycle
• D Extensive distribution into phagocytes and tissues with very high volume of distribution (~31 L/kg), with slow release from tissue stores ✓

Explanation

Azithromycin has an extraordinarily large volume of distribution (~31 L/kg) because it concentrates heavily in phagocytes (macrophages, neutrophils) and intracellular compartments—tissue-to-plasma ratios exceeding 100:1. This tissue sequestration creates a large reservoir from which drug is slowly released, giving a terminal tissue half-life of ~68 hours and maintaining antibacterial concentrations at infection sites for days after a short oral course. Plasma concentrations are actually quite low and rapid, which misleadingly implies the drug has cleared, when in fact tissue levels remain therapeutic.

Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.